Home > Healthcare > Medical Devices > Diagnostic Devices > reflux testing devices market
Get a free sample of Reflux Testing Devices Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Reflux Testing Devices Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
GERD is no longer a rare affliction; it is a widespread condition affecting a substantial portion of the population. In the U.S. alone, GERD is estimated to affect over 20% of adults regularly, with millions experiencing symptoms intermittently. Globally, GERD’s prevalence is on the rise and is one of the driving forces behind the surge in GERD diagnosis. For instance, a study published in the Journal of Gastroenterology and Hepatology found that 63% of respondents were familiar with GERD symptoms, indicating improved public awareness.
Furthermore, people are more informed than ever about GERD’s signs and symptoms, through an abundance of information available online and through healthcare providers. Public health campaigns, medical literature, and online resources have made it easier for individuals to recognize the signs of GERD, such as heartburn, regurgitation, and persistent coughing, leading to a proactive approach in seeking medical evaluation.
Medtronic, Biomedix, Johnson & Johnson Services, Inc, Diversatek, Inc., Laborie, Diversatek Healthcare, Creo Medical Group PLC, JINSHAN Science & Technology (Group) Co., Ltd., and Thermo Fisher Scientific are some of the major reflux testing device companies worldwide.
U.S. industry recorded USD 1 billion in revenue in 2022 and will experience appreciable growth from 2023-2032 owing to the presence of highly developed healthcare infrastructure in the region.
The reflux capsule product type segment will register 5.2% CAGR from 2023-2032 on account of their patient-friendly approach along with remarkable technological advancements.
Reflux testing devices market size was USD 3.2 billion in 2022 and will reach USD 5 billion by 2032 due to the increasing prevalence of gastroesophageal reflux disease (GERD) worldwide.